Equities Analysts Set Expectations for Tabula Rasa Healthcare Inc.’s Q3 2018 Earnings (TRHC)
Tabula Rasa Healthcare Inc. (NASDAQ:TRHC) – Research analysts at First Analysis issued their Q3 2018 EPS estimates for Tabula Rasa Healthcare in a note issued to investors on Monday. First Analysis analyst anticipates that the company will earn $0.15 per share for the quarter. First Analysis has a “Overweight” rating and a $41.00 price target on the stock.
Tabula Rasa Healthcare (NASDAQ:TRHC) last posted its quarterly earnings results on Monday, November 6th. The company reported $0.08 EPS for the quarter, beating the Zacks’ consensus estimate of $0.06 by $0.02. Tabula Rasa Healthcare had a negative net margin of 2.27% and a negative return on equity of 5.58%. The firm had revenue of $33.27 million for the quarter, compared to analysts’ expectations of $31.76 million. During the same quarter in the prior year, the company posted $0.06 earnings per share. The business’s revenue for the quarter was up 37.6% on a year-over-year basis.
Other equities research analysts have also recently issued research reports about the stock. Chardan Capital raised their target price on shares of Tabula Rasa Healthcare from $19.50 to $21.00 and gave the stock a “buy” rating in a report on Tuesday, August 8th. Robert W. Baird raised their target price on shares of Tabula Rasa Healthcare from $17.00 to $18.00 and gave the stock an “outperform” rating in a report on Tuesday, August 8th. Piper Jaffray Companies restated an “overweight” rating and issued a $20.00 target price (up previously from $19.00) on shares of Tabula Rasa Healthcare in a report on Wednesday, August 9th. UBS AG raised their target price on shares of Tabula Rasa Healthcare from $18.00 to $25.00 and gave the stock a “buy” rating in a report on Wednesday, August 30th. Finally, Wells Fargo & Company cut shares of Tabula Rasa Healthcare from an “outperform” rating to a “market perform” rating and raised their target price for the stock from $17.00 to $21.00 in a report on Thursday, September 7th. Three investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. The stock presently has a consensus rating of “Buy” and an average price target of $28.25.
Tabula Rasa Healthcare (NASDAQ TRHC) traded up $1.01 during trading hours on Tuesday, hitting $29.08. 101,700 shares of the stock were exchanged, compared to its average volume of 88,948. Tabula Rasa Healthcare has a 1 year low of $10.51 and a 1 year high of $31.05. The company has a debt-to-equity ratio of 0.47, a quick ratio of 0.66 and a current ratio of 0.73.
A number of institutional investors and hedge funds have recently added to or reduced their stakes in TRHC. Pier Capital LLC bought a new position in Tabula Rasa Healthcare in the third quarter worth approximately $4,151,000. Wasatch Advisors Inc. bought a new stake in shares of Tabula Rasa Healthcare during the 3rd quarter valued at $4,047,000. EAM Investors LLC bought a new stake in shares of Tabula Rasa Healthcare during the 3rd quarter valued at $3,931,000. Allianz Asset Management GmbH bought a new stake in shares of Tabula Rasa Healthcare during the 3rd quarter valued at $3,801,000. Finally, Paradigm Capital Management Inc. NY bought a new stake in shares of Tabula Rasa Healthcare during the 2nd quarter valued at $1,165,000. Institutional investors and hedge funds own 25.80% of the company’s stock.
In other Tabula Rasa Healthcare news, insider Orsula V. Knowlton sold 8,000 shares of the stock in a transaction that occurred on Wednesday, October 18th. The shares were sold at an average price of $26.68, for a total value of $213,440.00. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Insiders sold 24,000 shares of company stock worth $527,920 over the last quarter. Insiders own 45.80% of the company’s stock.
Tabula Rasa Healthcare Company Profile
Tabula Rasa HealthCare, Inc (Tabula Rasa), formerly CareKinesis, Inc, is a provider of patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations and manage risk. The Company delivers its solutions through a suite of technology-enabled products and services for medication risk management, which includes bundled prescription fulfillment and adherence packaging services for client populations with complex prescription needs.
Receive News & Ratings for Tabula Rasa Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tabula Rasa Healthcare Inc. and related companies with MarketBeat.com's FREE daily email newsletter.